Losartan vs Nivolumab
Losartan vs Nivolumab: Overview
This comparison examines the pharmacological differences between Losartan and Nivolumab.
Mechanism of Action
Losartan: Angiotensin II receptor type 1 antagonist.
Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.
Pharmacokinetics
Half-life: Losartan — 2 hours; Nivolumab — 27 days.
Chemical Properties
Molecular Formula: Losartan — C22H23ClN6O.
Molecular Weight: Losartan — 422.9200 g/mol.
Type: Losartan — Small molecule; Nivolumab — Antibody.